论文部分内容阅读
最近,参加了国家医药管理局组织的全国中药长远科研规划的调研工作,有机会接触了一些省、市、地区的中药科研和生产单位,了解到不少基本情况,从中也发现了目前中成药科研和生产方面的若干倾向性问题。这些倾向,如果不予纠正,将会妨碍中成药事业的健康成长。因此,我们认为有必要提出来,以引起有关方面的注意和重视。一、滋补类成药生产过多近年来,中成药生产的发展是很快的,这是一件好事,说明中成药产品的质量和疗效有所提高,广大病患者愿量服用中成药。但值得注意的是在迅速增长的中药工业总产值中,滋补类药品占着很大的比重。据统计,某些
Recently, he participated in the national long-term research plan for the research of traditional Chinese medicine organized by the State Administration of Pharmaceuticals. He had the opportunity to contact some provinces, cities, and regions in the research and production units of traditional Chinese medicine. He learned a lot of basic conditions and discovered the current Chinese patent medicines. Several tendencies in research and production. If these trends are not corrected, they will hinder the healthy growth of proprietary Chinese medicines. Therefore, we think it is necessary to put it forward so as to arouse the attention and attention of relevant parties. I. Overproduction of tonic-type medicines In recent years, the development of Chinese patent medicine production is very fast. This is a good thing, which shows that the quality and efficacy of Chinese patent medicine products have been improved, and the majority of patients are willing to take proprietary Chinese medicines. However, it is worth noting that in the rapidly growing total output value of the Chinese medicine industry, nourishing drugs account for a large proportion. According to statistics, some